(Q38597233)

4 September 2017

title

EBNA2 and Its Coactivator EBNA-LP. (English)

1 reference

4 September 2017

Bettina Kempkes

1

1 reference

4 September 2017

Paul D Ling

series ordinal

2

1 reference

4 September 2017

publication date

1 January 2015

1 reference

Current Topics in Microbiology and Immunology

4 September 2017

published in

1 reference

4 September 2017

volume

391

1 reference

4 September 2017

page(s)

35-59

1 reference

A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Early events in Epstein-Barr virus infection of human B lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Size and stability of the Epstein-Barr virus major internal repeat (IR-1) in Burkitt's lymphoma and lymphoblastoid cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus latent gene expression during the initiation of B cell immortalization

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

The conserved Mynd domain of BS69 binds cellular and oncoviral proteins through a common PXLXP motif

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Intranuclear localization of the transcription coadaptor CBP/p300 and the transcription factor RBP-Jk in relation to EBNA-2 and -5 in B lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

EBV EBNA 2 stimulates CDK9-dependent transcription and RNA polymerase II phosphorylation on serine 5.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus nuclear antigen 2 binds via its methylated arginine-glycine repeat to the survival motor neuron protein.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Spliced RNA from the IR1-U2 region of Epstein-Barr virus: presence of an open reading frame for a repetitive polypeptide

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Functional interaction of nuclear factor y and sp1 is required for activation of the epstein-barr virus C promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Molecular virology of Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus and virus human protein interaction maps

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Modulation of cellular gene expression in B lymphoma cells followingin vitro infection by Epstein-Barr virus (EBV)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Structural and Functional Characterization of a Complex between the Acidic Transactivation Domain of EBNA2 and the Tfb1/p62 Subunit of TFIIH

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

A region of herpes simplex virus VP16 can substitute for a transforming domain of Epstein-Barr virus nuclear protein 2

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

The spatial organization of DNA virus genomes in the nucleus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

PML and PML nuclear bodies: implications in antiviral defence

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Transcriptional coregulator SNW/SKIP: the concealed tie of dissimilar pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Mutational analysis of the J recombination signal sequence binding protein (RBP-J)/Epstein-Barr virus nuclear antigen 2 (EBNA2) and RBP-J/Notch interaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Truncated form of the Epstein-Barr virus protein EBNA-LP protects against caspase-dependent apoptosis by inhibiting protein phosphatase 2A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Characterization of DP103, a novel DEAD box protein that binds to the Epstein-Barr virus nuclear proteins EBNA2 and EBNA3C

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Protein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-association

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Notch and Wnt signaling: mimicry and manipulation by gamma herpesviruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus EBNA-LP and transcription regulation properties of pRB, p107 and p53 in transfection assays.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

EBNA2 and Activated Notch Induce Expression of BATF

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

EBV-encoded EBNA-5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF-expressing cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Structures of CSL, Notch and Mastermind proteins: piecing together an active transcription complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Crystal structure of the nuclear effector of Notch signaling, CSL, bound to DNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

CKII site in Epstein-Barr virus nuclear protein 2 controls binding to hSNF5/Ini1 and is important for growth transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Keeping a good pathway down: transcriptional repression of Notch pathway target genes by CSL proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Nuclear-cytoplasmic shuttling is not required for the Epstein-Barr virus EBNA-LP transcriptional coactivation function

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Modulation of Epstein-Barr virus nuclear antigen 2-dependent transcription by protein arginine methyltransferase 5.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus-recent advances

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

A somatic knockout of CBF1 in a human B-cell line reveals that induction of CD21 and CCR7 by EBNA-2 is strictly CBF1 dependent and that downregulation of immunoglobulin M is partially CBF1 independent

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Cellular target genes of Epstein-Barr virus nuclear antigen 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 function

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elements

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus nuclear antigen 2 induces FcRH5 expression through CBF1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Cell cycle activation by c-myc in a burkitt lymphoma model cell line.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Antagonistic effects of c-myc and Epstein-Barr virus latent genes on the phenotype of human B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Direct interactions between Epstein-Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Four EBNA2 domains are important for EBNALP coactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

PU box-binding transcription factors and a POU domain protein cooperate in the Epstein--Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Domains of the Epstein--Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

An Epstein-Barr virus transcript from a latently infected, growth-transformed B-cell line encodes a highly repetitive polypeptide

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Expression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus: exploiting the immune system

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus nuclear antigen 2 inhibits AID expression during EBV-driven B-cell growth.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

The Epstein-Barr Virus Nuclear Protein 2 Acidic Domain Forms a Complex with a Novel Cellular Coactivator That Can Interact with TFIIE

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-barr virus sequence variation-biology and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

A single amino acid in EBNA-2 determines superior B lymphoblastoid cell line growth maintenance by Epstein-Barr virus type 1 EBNA-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Functional cooperation of Epstein-Barr virus nuclear antigen 2 and the survival motor neuron protein in transactivation of the viral LMP1 promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Nonhuman primate models for Epstein-Barr virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Promoter-specific targeting of human SWI-SNF complex by Epstein-Barr virus nuclear protein 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

The human SNF5/INI1 protein facilitates the function of the growth arrest and DNA damage-inducible protein (GADD34) and modulates GADD34-bound protein phosphatase-1 activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

The conserved domain CR2 of Epstein-Barr virus nuclear antigen leader protein is responsible not only for nuclear matrix association but also for nuclear localization

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Identification of major phosphorylation sites of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP): ability of EBNA-LP to induce latent membrane protein 1 cooperatively with EBNA-2 is regulated by phosphorylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Mitosis-specific hyperphosphorylation of Epstein-Barr virus nuclear antigen 2 suppresses its function

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

A role for SKIP in EBNA2 activation of CBF1-repressed promoters

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_2

10.1007/978-3-319-22834-1_2

31 March 2020

Identifiers

DOI

1 reference

4 September 2017

1 reference